J&J Resolves Most Lawsuits Over Anti-Psychotic Drug, Reports $800M in Legal Expenses Over Issue
Carrier Management - Nov 01, 2021
J&J Resolves Most Lawsuits Over Anti-Psychotic Drug, Reports $800M in Legal Expenses Over Issue Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed ......
Recommended Articles
Posted: Apr 16, 2026
House Approves Aviation Safety Bill Based on Deadly Midair Collision An aviation safety bill seeking...
Posted: Apr 16, 2026
Britain Considers Expanding Ban on NDAs That Silence Workplace Abuse Complaints Britain may widen a...
Posted: Apr 16, 2026
U.S. Sustained Storm-Related Insured Losses Over $50B Three Years in a Row: Triple-I Tornadoes, hail...